18h Annual Peptide Therapeutics Symposium
October 16 – 17, 2023
Scripps Seaside Forum, La Jolla, CA |
| Monday, October 16, 2023 |
| 8:00am - 4:00pm | Registration Check-in
The Scripps Seaside Forum Lobby |
| 8:00am - 8:30am | Breakfast
The Scripps Seaside Forum Lobby |
| 8:30am - 4:45pm | 18th Annual Peptide Therapeutics Symposium
Samuel H. Scripps Auditorium |
| 8:30am - 8:35am | Opening Remarks
Adam Mezo, Ph.D.
President, Peptide Therapeutics Foundation
Executive Scientific Director, Discovery Biology Research Neurocrine Biosciences, Inc. |
| 8:35am - 10:05am | Plenary Lectures
Moderator: Sepideh Afshar
Senior Director and Peptide Discovery Group Leader
Eli Lilly and Company |
| 8:35am - 9:20am | Peptide Therapeutics for the Treatment of Obesity and Type 2 Diabetes
Ruth E. Gimeno, Ph.D.
Group Vice President, Diabetes, Obesity and Cardiometabolic Research
Eli Lilly and Company |
| 9:20am - 10:05am | Amylin: State of the Union
Thomas Lutz, Ph.D.
Professor in Veterinary Physiology, Institute of Veterinary Physiology, Vetsuisse Faculty
University of Zurich |
| 10:05am - 10:35am | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 10:35am - 12:05pm | Session I
Moderator: Bryan Fuchs, Ph.D.
Vice President, Gastroenterology
Ferring Pharmaceuticals |
| 10:35am - 11:05am | Harnessing the Power of Molecular Imaging for Precision Medicine: Radiolabeled Peptides, Antibodies, and Everything in Between
Weibo Cai, Ph.D.
Vilas Distinguished Achievement Professor of Radiology, Medical Physics, Materials Science & Engineering, Pharmaceutical Sciences
University of Wisconsin - Madison |
| 11:05am - 11:35am | Radionuclide Theranostics: Current State and Future Perspectives
Ken Herrmann, MD, MBA
Department Chair, Nuclear Medicine
Universitätsklinikum Essen, Germany |
| 11:35am - 12:05pm | Establishing a Novel Platform for Discovery of CPPs that Localize in Cytoplasm
Jinsha Liu, Ph.D.
Advisor
Eli Lilly and Company |
| 12:05pm - 1:05pm | Lunch & Poster Viewing
The Scripps Seaside Forum Lawn |
| 1:05pm - 2:35pm | Session II
Moderator: Antoine Henninot
Director
Takeda Pharmaceuticals |
| 1:05pm - 1:35pm | Development of Efruxifermin, an FGF21 Analog, for Treatment of Nonalcoholic Steatohepatitis (NASH)
Jonathan M. Young, Ph.D., J.D.
Co-Founder and Chief Operating Officer
Akero Therapeutics, Inc. |
| 1:35pm - 2:05pm | Safe and Effective Delivery of Nucleic Acids Using Proteolipid Vehicles Formulated with Fusion-Associated Small Transmembrane Proteins
John D. Lewis, Ph.D.
Founder & CEO
Entos Pharmaceuticals |
| 2:05pm - 2:35pm | Stealth Editing™ - A Novel Non-Immunogenic In Vivo Gene Editing Technology
Dietrich A. Stephan, Ph.D.
Founder & CEO
NeuBase Therapeutics |
| 2:35pm– 2:55pm | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 2:55pm - 4:25pm | Session III
Moderator: Ron He, PhD, MBA
Principal Scientist
Peptide Chemistry | Discovery Biologics
Neurocrine Biosciences, Inc |
| 2:55pm - 3:25pm | Neuregulin 4 (NRG4) as a New Hormonal Therapy for NASH-related Liver Cancer
Jiandie Lin, Ph.D.
Bradley M. Patten Collegiate Professor of Life Sciences, Professor of Cell & Developmental Biology, Research Professor in the Life Sciences Institute
University of Michigan |
| 3:25pm - 3:55pm | Activation of the Insulin Receptor by Insulin and Non-insulin Peptide: Application in Human Disease
Eunhee Choi, Ph.D.
Assistant Professor, Department of Pathology and Cell Biology Columbia University |
| 3:55pm - 4:25pm | The Structure-function of the Endocrine FGFs: Nature Repeats Itself
Archita Agrawal, Ph.D.
Postdoctoral Researcher
Salk Institute for Biological Studies |
| 4:25pm - 4:45pm | Tribute to Waleed Danho |
| 4:45pm - 6:15pm | Opening Reception
The Scripps Seaside Forum Lawn |
| Tuesday, October 17, 2023 |
| 8:00am - 10:00am | Registration Check-in
The Scripps Seaside Forum Lobby |
| 8:00am - 8:30am | Breakfast
The Scripps Seaside Forum Lobby |
| 8:30am - 12:30pm | 18th Annual Peptide Therapeutics Symposium
Samuel H. Scripps Auditorium |
| 8:30am - 8:45am | Welcoming Remarks
Phil Dawson, Ph.D.
Chairman of the Board, Peptide Therapeutics Foundation
Professor of Chemistry, Scripps Research
Dean of the Skaggs Graduate School of Chemistry and Biological Sciences |
| 8:45am - 10:15am | Plenary Lectures
Moderator: David Parkes
President
DGP Scientific Inc.
|
| 8:45am - 9:30am | The Interplay of Insulin and Glucagon: From Physiology to Pharmacology
David Maggs, MD, FRCP
Abvance Therapeutics
UT Health San Antonio TX |
| 9:30am - 10:15am | One Ellipsoid to Rule Them All — Cathelicidin-mimicking Peptoids that are Antiviral, Antibacterial & Antifungal and Well-tolerated in the Airways
Annelise E. Barron, Ph.D.
Associate Professor of Bioengineering
Stanford University, Schools of Medicine and Engineering |
| 10:15am - 10:45am | Beverage Break & Poster Viewing
The Scripps Seaside Forum Lobby |
| 10:45am - 12:15pm | Session IV
Moderator: Robert Hagopian
Director, Peptide Therapeutics Foundation
Director, Business Development, Group Pipeline
PolyPeptide
|
| 10:45am - 11:15am | Computational Design of Novel Peptides for SORT1 and Their Use in Oncology
Lucas Siow
Co-Founder & CEO
ProteinQure Inc. |
| 11:15am - 11:45am | Pegcetacoplan: the CMC Journey through Development to FDA Approval
Christopher P Holmes, Ph.D.
VP of Chemical and Pharmaceutical Development
Apellis |
| 11:45am - 12:15pm | TBD |
| 12:15pm - 12:30pm | Closing Remarks
Nick Cox, Ph.D.
Director, Peptide Therapeutics Foundation
Associate Director of Discovery Chemistry, Novo Nordisk |
| 12:30pm - 1:30pm | Networking Lunch
The Scripps Seaside Forum Lawn |
